243 related articles for article (PubMed ID: 26565015)
21. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
McConeghy KW; Bleasdale SC; Rodvold KA
Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343
[TBL] [Abstract][Full Text] [Related]
22. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.
Goldberg E; Paul M; Talker O; Samra Z; Raskin M; Hazzan R; Leibovici L; Bishara J
J Antimicrob Chemother; 2010 Aug; 65(8):1779-83. PubMed ID: 20507860
[TBL] [Abstract][Full Text] [Related]
23. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
Vernadakis S; Saner FH; Rath PM; Kaiser GM; Mathe Z; Treckmann J; Paul A
Transpl Infect Dis; 2009 Aug; 11(4):346-8. PubMed ID: 19497075
[TBL] [Abstract][Full Text] [Related]
24. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
25. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.
Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H
Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021
[TBL] [Abstract][Full Text] [Related]
26. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.
Gritsenko D; Fedorenko M; Ruhe JJ; Altshuler J
Clin Ther; 2017 Jan; 39(1):212-218. PubMed ID: 28038791
[TBL] [Abstract][Full Text] [Related]
27. Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia.
Neuner EA; Casabar E; Reichley R; McKinnon PS
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):228-33. PubMed ID: 20542203
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of persistent MRSA bacteremia using high-dose daptomycin combined with rifampicin.
Hagiya H; Terasaka T; Kimura K; Satou A; Asano K; Waseda K; Hanayama Y; Otsuka F
Intern Med; 2014; 53(18):2159-63. PubMed ID: 25224207
[TBL] [Abstract][Full Text] [Related]
29. Observational studies of salvage treatment for persistent bacteremia: beware of survivor treatment selection bias.
Tattevin P; Uhel F; Fily F
Clin Infect Dis; 2009 Dec; 49(12):1960; author reply 1961. PubMed ID: 19929392
[No Abstract] [Full Text] [Related]
30. [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].
Gudiol F; Aguado JM; Pascual A; Pujol M; Almirante B; Miró JM; Cercenado E; Domínguez Mde L; Soriano A; Rodríguez-Baño J; Vallés J; Palomar M; Tornos P; Bouza E;
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):105-15. PubMed ID: 19254641
[TBL] [Abstract][Full Text] [Related]
31. Treatment of infections due to resistant Staphylococcus aureus.
Anstead GM; Cadena J; Javeri H
Methods Mol Biol; 2014; 1085():259-309. PubMed ID: 24085702
[TBL] [Abstract][Full Text] [Related]
32. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R
Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462
[TBL] [Abstract][Full Text] [Related]
33. Ceftaroline as salvage therapy for complicated MRSA bacteremia: case series and analysis.
Bhowmick T; Liu C; Imp B; Sharma R; Boruchoff SE
Infection; 2019 Aug; 47(4):629-635. PubMed ID: 30955166
[TBL] [Abstract][Full Text] [Related]
34. Impact of source of infection and vancomycin AUC0-24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Ghosh N; Chavada R; Maley M; van Hal SJ
Clin Microbiol Infect; 2014 Dec; 20(12):O1098-105. PubMed ID: 24890030
[TBL] [Abstract][Full Text] [Related]
35. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
[TBL] [Abstract][Full Text] [Related]
36. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin.
Hussain A; Kairamkonda V; Jenkins DR
J Med Microbiol; 2011 Mar; 60(Pt 3):381-383. PubMed ID: 21127158
[TBL] [Abstract][Full Text] [Related]
38. Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored Over Vancomycin?
Vu M; Smith KJ; Aspinall SL; Clancy CJ; Buehrle DJ
Clin Drug Investig; 2021 Oct; 41(10):885-894. PubMed ID: 34480725
[TBL] [Abstract][Full Text] [Related]
39. Morbidity, mortality, and management of methicillin-resistant S. aureus bacteremia in the USA: update on antibacterial choices and understanding.
Ortwine JK; Bhavan K
Hosp Pract (1995); 2018 Apr; 46(2):64-72. PubMed ID: 29400119
[TBL] [Abstract][Full Text] [Related]
40. Methicillin-resistant Staphylococcus aureus therapy: past, present, and future.
Rodvold KA; McConeghy KW
Clin Infect Dis; 2014 Jan; 58 Suppl 1():S20-7. PubMed ID: 24343828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
